Variant report
Variant | nsv606293 |
---|---|
Chromosome Location | chr7:15258456-15265037 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6977610 | chr7:15258456-15258457 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs576048119 | chr7:15258491-15258492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544929355 | chr7:15258499-15258500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555254899 | chr7:15258520-15258521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186557476 | chr7:15258532-15258533 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540788220 | chr7:15258558-15258559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386710654 | chr7:15258560-15258561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6977651 | chr7:15258561-15258562 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs545927235 | chr7:15258568-15258569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199532058 | chr7:15258661-15258662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562535649 | chr7:15258665-15258666 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373869828 | chr7:15258693-15258694 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191189309 | chr7:15258694-15258695 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548099361 | chr7:15258707-15258708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567978417 | chr7:15258742-15258743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527524811 | chr7:15258747-15258748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547544250 | chr7:15258771-15258772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183741783 | chr7:15258812-15258813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113758501 | chr7:15258820-15258821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188506737 | chr7:15258927-15258928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575451564 | chr7:15258982-15258983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556252941 | chr7:15258988-15258989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373681391 | chr7:15259023-15259024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569670587 | chr7:15259088-15259089 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146760556 | chr7:15259089-15259090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568542336 | chr7:15259119-15259120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7810617 | chr7:15259130-15259131 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs575061916 | chr7:15259131-15259132 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140372462 | chr7:15259135-15259136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542481608 | chr7:15259177-15259178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4342487 | chr7:15259183-15259184 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs76110939 | chr7:15259231-15259232 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546289671 | chr7:15259249-15259250 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185012828 | chr7:15259256-15259257 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576042383 | chr7:15259257-15259258 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541804118 | chr7:15259286-15259287 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190305055 | chr7:15259375-15259376 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527578619 | chr7:15259389-15259390 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547316497 | chr7:15259420-15259421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564315949 | chr7:15259428-15259429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532936493 | chr7:15259434-15259435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549922959 | chr7:15259449-15259450 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10267632 | chr7:15259451-15259452 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs535477012 | chr7:15259467-15259468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548978554 | chr7:15259496-15259497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62448951 | chr7:15259551-15259552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181990671 | chr7:15259580-15259581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554130642 | chr7:15259581-15259582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114582960 | chr7:15259583-15259584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186373316 | chr7:15259592-15259593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:15249400-15260000 | Weak transcription | Psoas Muscle | Psoas |
2 | chr7:15253600-15264800 | Weak transcription | Liver | Liver |
3 | chr7:15255800-15260200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr7:15256600-15260200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr7:15256600-15261200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr7:15258000-15258800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
7 | chr7:15258200-15259200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr7:15258200-15260000 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr7:15258800-15259800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr7:15259200-15259400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr7:15259200-15260200 | Enhancers | HUVEC | blood vessel |
12 | chr7:15259400-15259600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr7:15259600-15259800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr7:15259800-15261200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr7:15260000-15260200 | Enhancers | Psoas Muscle | Psoas |
16 | chr7:15260200-15260600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
17 | chr7:15260200-15260600 | Weak transcription | HUVEC | blood vessel |
18 | chr7:15260600-15261000 | Enhancers | HUVEC | blood vessel |
19 | chr7:15260600-15261200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
20 | chr7:15260800-15261200 | Enhancers | H9 Cell Line | embryonic stem cell |
21 | chr7:15264800-15266000 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr7:15264800-15267200 | Enhancers | Liver | Liver |